These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8321021)
21. Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia. Sheng XM; Kawamura M; Ohnishi H; Ida K; Hanada R; Kojima S; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y Leuk Res; 1997 Aug; 21(8):697-701. PubMed ID: 9379676 [TBL] [Abstract][Full Text] [Related]
22. Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome. Jekic B; Novakovic I; Lukovic L; Kuzmanovic M; Popovic B; Milasin J; Bunjevacki G; Damnjanovic T; Cvjeticanin S; Bunjevacki V Cancer Genet Cytogenet; 2006 Apr; 166(2):163-5. PubMed ID: 16631474 [TBL] [Abstract][Full Text] [Related]
23. Low frequency of RAS gene mutations and absence of mutations within the FLR exon of NF1 in patients with therapy-related leukemias. Borkhardt A; Brettreich S; Borkhardt AK; Repp R; Harbott J; Kreuder J; Lampert F Leukemia; 1995 Oct; 9(10):1790-1. PubMed ID: 7564528 [No Abstract] [Full Text] [Related]
24. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia. Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005 [TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Lorenzo F; Nishii K; Monma F; Kuwagata S; Usui E; Shiku H Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529 [TBL] [Abstract][Full Text] [Related]
26. Absence of point mutations in a functionally important part of the extracellular domain of the c-kit proto-oncogene in a series of patients with acute myeloid leukemia (AML). Arland M; Fiedler W; Samalecos A; Hossfeld DK Leukemia; 1994 Mar; 8(3):498-501. PubMed ID: 8127154 [TBL] [Abstract][Full Text] [Related]
27. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations. Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035 [TBL] [Abstract][Full Text] [Related]
28. Detection of p53 gene mutations in human leukemia by PCR-SSCP analysis and direct nucleotide sequencing. Wang R; Yu Z; Gu J; Li D; Wang M; Cao Y Chin Med J (Engl); 1998 Apr; 111(4):339-42. PubMed ID: 10374399 [TBL] [Abstract][Full Text] [Related]
29. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype. Zhang Y; Zhang M; Yang L; Xiao Z Leuk Res; 2007 Jan; 31(1):109-11. PubMed ID: 16678898 [TBL] [Abstract][Full Text] [Related]
30. p53 mutation in the myelodysplastic syndromes. Adamson DJ; Dawson AA; Bennett B; King DJ; Haites NE Br J Haematol; 1995 Jan; 89(1):61-6. PubMed ID: 7833278 [TBL] [Abstract][Full Text] [Related]
31. Mutations in ras genes in myelocytic leukemias and myelodysplastic syndromes. Bartram CR Blood Cells; 1988; 14(2-3):533-8. PubMed ID: 3067784 [TBL] [Abstract][Full Text] [Related]
32. Retrospective analysis of ras gene activation in myeloid leukemic cells. Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160 [TBL] [Abstract][Full Text] [Related]
33. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Janssen JW; Steenvoorden AC; Lyons J; Anger B; Böhlke JU; Bos JL; Seliger H; Bartram CR Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9228-32. PubMed ID: 3122217 [TBL] [Abstract][Full Text] [Related]
34. Analysis of NF1 gene mutations in neurofibromatosis type 1 patients in Japan. Hatta N; Horiuchi T; Fujita S Biochem Biophys Res Commun; 1994 Feb; 199(1):207-12. PubMed ID: 8123014 [TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia. Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802 [TBL] [Abstract][Full Text] [Related]
36. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia. Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956 [TBL] [Abstract][Full Text] [Related]
37. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes. Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874 [TBL] [Abstract][Full Text] [Related]
38. The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML. Kaeferstein A; Krug U; Tiesmeier J; Aivado M; Faulhaber M; Stadler M; Krauter J; Germing U; Hofmann WK; Koeffler HP; Ganser A; Verbeek W Leukemia; 2003 Feb; 17(2):343-9. PubMed ID: 12592334 [TBL] [Abstract][Full Text] [Related]
39. Rearrangement and expression of the p53 gene in myelodysplastic syndrome and acute myeloid leukemia. Fenaux P; Collyn d'Hooghe M; Jonveaux P; Lai JL; Bauters F; Loucheux MH; Kerckaert JP Nouv Rev Fr Hematol (1978); 1990; 32(5):341-4. PubMed ID: 2099408 [TBL] [Abstract][Full Text] [Related]
40. Methylation status of c-myc oncogene in leukemic cells: hypomethylation in acute leukemia derived from myelodysplastic syndromes. Tsukamoto N; Morita K; Karasawa M; Omine M Exp Hematol; 1992 Oct; 20(9):1061-4. PubMed ID: 1468540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]